# HS Research Update (May 20, 2026): What's New on PubMed?

Canonical URL: https://www.acneinversa.life/en/blog/hs-research-update-2026-05-20/
Markdown URL: https://www.acneinversa.life/en/blog/hs-research-update-2026-05-20.md
Plain text URL: https://www.acneinversa.life/en/blog/hs-research-update-2026-05-20.txt
Language: en
Category: Research
Published: 2026-05-20
Last updated: 2026-05-20
Last editorially reviewed: 2026-05-20
Next scheduled review: 2027-05-20

Author: Dr. rer. nat. Dennis Alexander Kwiatkowski (Biochemist, Scientific Writer and Pharma Expert)
Scientific editor: Dr. rer. nat. Dennis Alexander Kwiatkowski
Reviewer qualifications: Biochemist, Scientific Writer and Pharma Expert
Review scope: Scientific literature, clinical guidelines, sources, and editorial clarity
Clinical reviewer: No independent clinical review
Tags: Acne Inversa, Hidradenitis Suppurativa, HS, Research, hidradenitis suppurativa, acne inversa, research update, biologics, comorbidities, diagnostic delay, pain, quality of life, surgery

> A patient-friendly overview of new PubMed publications on Hidradenitis suppurativa (Acne inversa) – with sources, clear limitations, and no medical advice.

Medical disclaimer: This website is for general educational information only and does not replace medical advice, diagnosis, or treatment. Please speak with qualified medical professionals about symptoms or treatment decisions.

## Article

Note: This article is an editorial overview and **has not been medically reviewed**. It does not replace medical advice, diagnosis, or treatment.

## What this update covers

- Search query: **("hidradenitis suppurativa" OR "acne inversa")**
- Entrez date field: `edat`
- Time period: **May 12, 2026** to **May 20, 2026**
- Newly added PubMed entries: **15**

## Key findings

In short: this week's abstracts focus on patient-relevant outcomes (pain/quality of life), practical care questions, and signals related to comorbidities.

- Comorbidities and systemic aspects (e.g., metabolic, musculoskeletal, IBD) come up repeatedly. (PMIDs 42147604, 42117990, 42153035, 42156635)
- Some abstracts address surgical/structural issues (e.g., fistulas/complications) related to HS care. (PMIDs 42131295, 42137224, 42117990)
- Pain and disease control are increasingly being treated as explicit study endpoints and goals. (PMIDs 42131295, 42137224)
- Several abstracts focus on quality of life, stigma, and patient-relevant outcome measures (e.g., DLQI/HiSQOL). (PMIDs 42131295, 42137224)

## What this could mean for patients (cautiously, not advice)

If you live with HS, research updates can help you understand what is currently being studied – for example, which endpoints (pain, quality of life) researchers measure or which comorbidities are increasingly part of the discussion. If the condition is new to you, our overview of [what Acne inversa is](/en/blog/what-is-acne-inversa/) may provide helpful context for these terms.

But even when a study sounds promising, it usually doesn't tell you what's right **for you personally**. Consider using new findings as [questions for your next doctor's appointment](/en/blog/15-questions-to-ask-your-dermatologist/) (e.g., "What goals are realistic for me?" or "Which related conditions should we watch for?"), not as instructions.

## What we don't know / Limitations

- This update includes **only** PubMed entries with an abstract (without an abstract, a reliable summary is only possible to a limited extent).
- The studies vary widely (design, populations, outcome measures).
- This update does **not** provide treatment recommendations and cannot assess individual risk.

## Overview of publications

- Publications (with abstracts) in this period: **15**
- Common themes: comorbidities, quality of life, biologics, surgery, pain
- Comparison with the previous week: not yet available (this is the first update in this series).
- No guideline-/NEJM-/Lancet-type high-impact hits with abstracts in this period.
- Featured publication: Clinical, Cosmetic and Investigational Dermatology – focus on quality of life/disease burden and how studies measure it. (PMID 42131295)

## Important: Decisions belong in conversation with medical professionals

If anything here concerns or interests you, use it as a conversation starter for your next appointment. Recognizing patterns early can also be important – see our guide on [recognizing Hidradenitis suppurativa before it progresses](/en/blog/recognizing-hidradenitis-suppurativa-early/). Decisions should always be made together with qualified medical professionals.

## Sources & original publications

Each point below refers to an original source (PubMed link as well as DOI/PMCID, where available).

## FAQ

### What does this HS research update cover?

It summarizes 15 PubMed publications on Hidradenitis suppurativa (Acne inversa) indexed between May 12 and May 20, 2026, with a focus on quality of life, comorbidities, surgery, and pain.

### Is this medical advice?

No. This is an editorial overview for patient education. It has not been medically reviewed and does not replace advice, diagnosis, or treatment by qualified medical professionals.

### How should I use this update?

Use it as a conversation starter for your next dermatology appointment – for example, to ask about realistic treatment goals or which comorbidities should be monitored.

### Why are quality-of-life measures important in HS research?

Because HS affects pain, mental health, and everyday functioning, researchers increasingly use patient-reported outcome measures (e.g., DLQI or HiSQOL) to capture the true burden beyond visible skin changes.

## References

1. The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa-A Narrative Review. - Dermatology and therapy, 2026 — PMID 42156635 · DOI 10.1007/s13555-026-01733-x - https://pubmed.ncbi.nlm.nih.gov/42156635/
2. Global Healthcare Study on Psoriasis (GHSP): cohort profile and first findings. - BMJ open, 2026 — PMID 42156142 · DOI 10.1136/bmjopen-2025-112891 - https://pubmed.ncbi.nlm.nih.gov/42156142/
3. Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update. - International journal of dermatology, 2026 — PMID 42144705 · DOI 10.1111/ijd.70443 - https://pubmed.ncbi.nlm.nih.gov/42144705/
4. Patients' preference regarding patient reported outcome measures (PROMs) for hidradenitis suppurativa, a cross-sectional multi-center study. - Dermatology (Basel, Switzerland), 2026 — PMID 42139161 · DOI 10.1159/000552227 - https://pubmed.ncbi.nlm.nih.gov/42139161/
5. New Hidradenitis Suppurativa in Children: Influence of Neighborhood Socioeconomic Status. - Pediatric dermatology, 2026 — PMID 42132305 · DOI 10.1111/pde.70265 - https://pubmed.ncbi.nlm.nih.gov/42132305/
6. Laboratory Parameters Can Serve as Objective Auxiliary Tools for Assessing Disease Severity in Hidradenitis Suppurativa: A 5-Year Period Single-Center Retrospective Study. - Clinical, cosmetic and investigational dermatology, 2026 — PMID 42153035 · DOI 10.2147/CCID.S601760 · PMCID PMC13180368 - https://pubmed.ncbi.nlm.nih.gov/42153035/
7. Spatially Profiling Trace Cytokine Signatures From Microscopically Derived Skin Samples to Probe Skin Disease Inflammation. - Small methods, 2026 — PMID 42124321 · DOI 10.1002/smtd.202501964 - https://pubmed.ncbi.nlm.nih.gov/42124321/
8. High-Frequency Ultrasound in Hidradenitis Suppurativa: From Lesion Detection to Iconographic Lesion-Level Management. - American journal of clinical dermatology, 2026 — PMID 42118485 · DOI 10.1007/s40257-026-01040-3 - https://pubmed.ncbi.nlm.nih.gov/42118485/
9. Defining Minimal Disease Activity in Hidradenitis Suppurativa: A New Clinical Target. - Journal of cutaneous medicine and surgery, 2026 — PMID 42117442 · DOI 10.1177/12034754261442925 - https://pubmed.ncbi.nlm.nih.gov/42117442/
10. Impact of Bariatric Surgery on Quality of Life and Psychological Well-Being Among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study. - Clinical, cosmetic and investigational dermatology, 2026 — PMID 42131295 · DOI 10.2147/CCID.S584656 · PMCID PMC13165486 - https://pubmed.ncbi.nlm.nih.gov/42131295/
11. The Multifaceted Role of Keratinocytes in Hidradenitis Suppurativa Pathogenesis. - Experimental dermatology, 2026 — PMID 42124376 · DOI 10.1111/exd.70269 · PMCID PMC13168781 - https://pubmed.ncbi.nlm.nih.gov/42124376/
12. How I Do It: MRI Approach to Perianal Fistulas. - Radiology, 2026 — PMID 42117990 · DOI 10.1148/radiol.251909 - https://pubmed.ncbi.nlm.nih.gov/42117990/
13. Patterns of Musculoskeletal Involvement in Hidradenitis Suppurativa: A Pilot Study. - Cureus, 2026 — PMID 42147604 · DOI 10.7759/cureus.106996 · PMCID PMC13172419 - https://pubmed.ncbi.nlm.nih.gov/42147604/
14. Severe Penoscrotal Lymphedema in Hidradenitis Suppurativa: A Case Series. - Skin appendage disorders, 2026 — PMID 42137224 · DOI 10.1159/000551470 · PMCID PMC13171140 - https://pubmed.ncbi.nlm.nih.gov/42137224/
15. Viable vs. Nonviable Microbiota Evaluation of the Hair Follicle and Scalp Microbiome. - Methods in molecular biology (Clifton, N.J.), 2026 — PMID 42149452 · DOI 10.1007/978-1-0716-5253-4_18 - https://pubmed.ncbi.nlm.nih.gov/42149452/